Text Size
673 studies found for:    Attention Deficit-Hyperactivity Disorder

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Attention Deficit-Hyperactivity Disorder
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: KAPVAY™ (clonidine hydrochloride);   Drug: Placebo
2 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
3 Completed An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride
4 Completed
Has Results 		A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: Placebo
5 Completed
Has Results 		Open-Label, Chronic Exposure, Safety Study of CLONICEL (Clonidine HCl Sustained Release) in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: CLONICEL (Clonidine HCl sustained release)
6 Completed
Has Results 		An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: Vyvanse (lisdexamfetamine dimesylate), NRP104
7 Not yet recruiting Effect of Methylphenidate on Connectivity
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Methylphenidate;   Other: Placebo
8 Enrolling by invitation Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
Condition: Attention Deficit-hyperactivity Disorder
Intervention: Behavioral: Clinical decision support for medication titration
9 Completed Pilot Study of Duloxetine in Adult Attention Deficit Hyperactivity Disorder(ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: duloxetine;   Drug: placebo
10 Terminated
Has Results 		Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE
Conditions: Attention Deficit Hyperactivity Disorder;   Cannabis Abuse
Intervention: Drug: Atomoxetine
11 Unknown † A Pilot Trial of Homeopathic Treatment for Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Other: Homeopathic Remedies
12 Completed
Has Results 		Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine;   Drug: Placebo
13 Not yet recruiting The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
14 Completed A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
15 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
16 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
17 Completed
Has Results 		Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)
Conditions: Attention Deficit Hyperactivity Disorder;   Reading Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: placebo
18 Completed Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Education
19 Completed
Has Results 		Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine Hydrochloride;   Drug: Atomoxetine hydrochloride
20 Recruiting Adult Attention Deficit Hyperactivity Disorder
Condition: Adult Attention Deficit Hyperactivity Disorder
Interventions: Drug: SEP-225289;   Drug: Placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years